To evaluate the potential induction of cell death, we treated the breast cancer cell lines with the agents alone or in combination with the CHK1 inhibitor, and after 72 h of treatment, exposed them to an Annexin V/PI solution to allow cell death determination by flow cytometry. Here, ANXA5 is linked to breast cancer.